| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 51.5% | 35/68 |
| Female | 48.5% | 33/68 |
| Indifferent | 0% | 0/68 |
| Unknown | 0% | 0/68 |
| General | ||
| 1.5% | 1/68 | |
| 2.9% | 2/68 | |
| 2.9% | 2/68 | |
| 20.6% | 14/68 | |
| 13.2% | 9/68 | |
| 5.9% | 4/68 | |
| 89.7% | 61/68 | |
| 72.1% | 49/68 | |
| 82.4% | 56/68 | |
| 84.5% | 49/58 | |
| Neurology | ||
| 100% | 68/68 | |
| 57.4% | 39/68 | |
| 55.9% | 38/68 | |
| Facial abnormalities | ||
| 14.7% | 10/68 | |
| 54.4% | 37/68 | |
| 17.6% | 12/68 | |
| 23.5% | 16/68 | |
| Visual and hearing impairments | ||
| 1.5% | 1/68 | |
| 27.9% | 19/68 | |
| Heart | ||
| 19.1% | 13/68 | |
| Pulmonary | ||
| 60% | 6/10 | |
| Gastrointestinal | ||
| 86.8% | 59/68 | |
| Urogenital | ||
| 14.7% | 10/68 | |
| Skeleton | ||
| 54.4% | 37/68 | |
| Skin / Hair / Nails | ||
| 17.6% | 12/68 | |
| Endocrine / Immunological / Metabolic | ||
| 20.6% | 14/68 | |
| 10.3% | 7/68 | |
| 7.4% | 5/68 | |
| Neoplasia | ||
| 2.9% | 2/68 | |
| Inheritance | ||
| 100% | 58/58 | |
PURA